{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:00:01Z","timestamp":1793314801649,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["hCoV-19\/Taiwan\/4\/2020"],"award-info":[{"award-number":["hCoV-19\/Taiwan\/4\/2020"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-001-002"],"award-info":[{"award-number":["109-2314-B-001-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-3114-Y-001-001"],"award-info":[{"award-number":["109-3114-Y-001-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2314-B-001-008"],"award-info":[{"award-number":["MOST 109-2314-B-001-008"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["MOST-108-3114-Y-001-002"],"award-info":[{"award-number":["MOST-108-3114-Y-001-002"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-CFII-108-102"],"award-info":[{"award-number":["AS-CFII-108-102"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-CFII-108-115"],"award-info":[{"award-number":["AS-CFII-108-115"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-KPQ-109-BioMed"],"award-info":[{"award-number":["AS-KPQ-109-BioMed"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-SUMMIT-109"],"award-info":[{"award-number":["AS-SUMMIT-109"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ebiom.2021.103712","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T06:37:42Z","timestamp":1637822262000},"page":"103712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro"],"prefix":"10.1016","volume":"74","author":[{"given":"Hsiang-Chi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ju","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Che","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cheng","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Mao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Pu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Tse","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chun","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Jiun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1987-2653","authenticated-orcid":false,"given":"Te-An","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0580-7765","authenticated-orcid":false,"given":"Fu-An","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hua","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2021.103712_bib0001","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ebiom.2021.103712_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ebiom.2021.103712_bib0005","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ebiom.2021.103712_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15585\/mmwr.mm7003e2","article-title":"Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021","volume":"70","author":"Galloway","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ebiom.2021.103712_bib0007","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2021.2294","article-title":"SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities","volume":"325","author":"Walensky","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.ebiom.2021.103712_bib0008","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","author":"Zhou","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0009","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein","volume":"6","author":"Casalino","year":"2020","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.ebiom.2021.103712_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/vim.2020.0174","article-title":"The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2\/ACE2 and Immunological Responses","volume":"34","author":"Hern\u00e1ndez","year":"2021","journal-title":"Viral Immunol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0011","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1038\/s41598-018-22345-2","article-title":"Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer","volume":"8","author":"Fan","year":"2018","journal-title":"Scientific reports"},{"key":"10.1016\/j.ebiom.2021.103712_bib0012","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2009.12.008","article-title":"Metabolism, cell surface organization, and disease","volume":"139","author":"Dennis","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0013","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1039\/B907931A","article-title":"The repertoire of glycan determinants in the human glycome","volume":"5","author":"Cummings","year":"2009","journal-title":"Molecular bioSystems"},{"key":"10.1016\/j.ebiom.2021.103712_bib0014","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cell.2008.11.047","article-title":"Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms","volume":"136","author":"Ruiz-Canada","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0015","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.ebiom.2021.103712_bib0016","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.ebiom.2021.103712_bib0017","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1096\/fj.201802044RR","article-title":"Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction","volume":"33","author":"Lu","year":"2019","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01443-19","article-title":"Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein","volume":"93","author":"Zhu","year":"2019","journal-title":"Journal of virology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0019","unstructured":"A. Casas-Sanchez et\u00a0al., Protein <em>N<\/em>-glycosylation is essential for SARS-CoV-2 infection. bioRxiv 10.1101\/2021.02.05.429940, 2021.2002.2005.429940 (2021)."},{"key":"10.1016\/j.ebiom.2021.103712_bib0020","first-page":"13","article-title":"Antibody-Drug Conjugates: The Last Decade","author":"Joubert","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ebiom.2021.103712_bib0021","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2007.03.052","article-title":"Integrative genomic approaches identify IKBKE as a breast cancer oncogene","volume":"129","author":"Boehm","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0022","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2021.103712_bib0023","article-title":"The ProteomeXchange consortium in 2020: enabling 'big data' approaches in proteomics","volume":"48","author":"Deutsch","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2021.103712_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12896-017-0365-2","article-title":"AAV vector distribution in the mouse respiratory tract following four different methods of administration","volume":"17","author":"Santry","year":"2017","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009758","article-title":"Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19","volume":"17","author":"Sun","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2021.103712_bib0026","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41431-020-0636-6","article-title":"The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic","volume":"28","author":"Initiative","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ebiom.2021.103712_bib0027","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a013359","article-title":"N-linked protein glycosylation in the endoplasmic reticulum","volume":"5","author":"Breitling","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0028","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JVI.01705-10","article-title":"N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN","volume":"85","author":"Londrigan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0029","first-page":"1","article-title":"The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients","author":"Hariharan","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.598444","article-title":"NF-\u03baB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients","volume":"11","author":"Kircheis","year":"2020","journal-title":"Front Immunol"},{"issue":"2018","key":"10.1016\/j.ebiom.2021.103712_bib0031","article-title":"STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion","volume":"9","author":"Hsu","year":"1908","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2021.103712_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2008.03.004","article-title":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2","volume":"136","author":"Wang","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.ebiom.2021.103712_bib0033","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.apsb.2020.04.012","article-title":"Recent advances of antibody drug conjugates for clinical applications","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ebiom.2021.103712_bib0034","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103712_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2019.06.008","article-title":"Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1\/PD-L1 Therapeutic Efficacy","volume":"36","author":"Lee","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0036","article-title":"Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103712_bib0037","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chom.2021.02.010","article-title":"The great escape? SARS-CoV-2 variants evading neutralizing responses","volume":"29","author":"Pr\u00e9vost","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2021.103712_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.02.033","article-title":"Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera","author":"Supasa","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0039","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4155\/bio.13.57","article-title":"Novel detection of DNA-alkylated adducts of antibody-drug conjugates with potentially unique preclinical and biomarker applications","volume":"5","author":"Thevanayagam","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ebiom.2021.103712_bib0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nbt.2289","article-title":"The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma","volume":"30","author":"Senter","year":"2012","journal-title":"Nature biotechnology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0041","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103712_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00262-0","article-title":"SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity","author":"Ramanathan","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103712_bib0044","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2021.103712_bib0045","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1038\/s41598-020-71748-7","article-title":"Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition","volume":"10","author":"Grant","year":"2020","journal-title":"Scientific reports"},{"key":"10.1016\/j.ebiom.2021.103712_bib0046","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nchembio.1403","article-title":"Adaptive immune activation: glycosylation does matter","volume":"9","author":"Wolfert","year":"2013","journal-title":"Nature chemical biology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0047","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/eji.1830241017","article-title":"Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans","volume":"24","author":"Doe","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0048","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.4049\/jimmunol.0804287","article-title":"Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0049","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1128\/JVI.01548-10","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions","volume":"84","author":"Helle","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1742-4690-4-89","article-title":"Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS","volume":"4","author":"Sterjovski","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0051","first-page":"1","article-title":"Glycosylation is a key in SARS-CoV-2 infection","author":"Reis","year":"2021","journal-title":"Journal of molecular medicine (Berlin, Germany)"},{"key":"10.1016\/j.ebiom.2021.103712_bib0052","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell host & microbe"},{"key":"10.1016\/j.ebiom.2021.103712_bib0053","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1073\/pnas.93.1.7","article-title":"Interactions of protein antigens with antibodies","volume":"93","author":"Davies","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ebiom.2021.103712_bib0054","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1016\/j.vaccine.2020.08.032","article-title":"Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present \u03b1-gal epitopes","volume":"38","author":"Galili","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2021.103712_bib0055","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1038\/s41598-020-71748-7","article-title":"Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition","volume":"10","author":"Grant","year":"2020","journal-title":"Scientific reports"},{"key":"10.1016\/j.ebiom.2021.103712_bib0056","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nchembio.2194","article-title":"Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells","volume":"12","author":"Lopez-Sambrooks","year":"2016","journal-title":"Nature chemical biology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0057","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61552","article-title":"Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration","volume":"9","author":"Yang","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2021.103712_bib0058","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0059","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10875-020-00905-4","article-title":"N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects","volume":"41","author":"Nunes-Santos","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ebiom.2021.103712_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/v13050808","article-title":"Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2","volume":"13","author":"Rajasekharan","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2021.103712_bib0061","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/glycob\/cwaa091","article-title":"The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication","volume":"31","author":"Clarke","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.ebiom.2021.103712_bib0062","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","article-title":"Antibody-drug conjugates in cancer therapy","volume":"64","author":"Sievers","year":"2013","journal-title":"Annu Rev Med"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2021.103712_bib0063","first-page":"S142","article-title":"Receptor-binding domain as a target for developing SARS vaccines","volume":"5","author":"Zhu","year":"2013","journal-title":"Journal of thoracic disease"},{"key":"10.1016\/j.ebiom.2021.103712_bib0064","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2021.103712_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antiviral research"},{"key":"10.1016\/j.ebiom.2021.103712_bib0066","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/0008-5472.CAN-18-0505","article-title":"Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors","volume":"78","author":"Sambrooks","year":"2018","journal-title":"Cancer Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:48Z","timestamp":1778873688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421005065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":65,"alternative-id":["S2352396421005065"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103712","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103712"}}